Enterococcus faecium is a Gram-positive bacterium that naturally inhabits the gastrointestinal tracts of humans and animals. First classified under the Streptococcus genus in 1899, this microorganism was later reassigned to the Enterococcus genus in 1984, following genetic studies that revealed closer nucleic acid similarities with enterococci. Today, E. faecium is recognized both for its beneficial probiotic functions and for its potential to cause serious infections, particularly in hospital settings.
While E. faecium is a natural component of the gut microbiota, it is also an opportunistic pathogen. In individuals with compromised immune systems-such as the elderly or hospitalized patients-it can cause a range of infections, including urinary tract infections, bloodstream infections, and endocarditis. These infections are often associated with healthcare environments, where the bacteria can be transmitted via contaminated medical devices, surfaces, or even healthcare workers' hands. In fact, Enterococcus faecium, alongside Enterococcus faecalis, is one of the most common causes of hospital-acquired (nosocomial) infections. Since the 1970s, these two species have been recognized as major contributors to antibiotic-resistant infections in clinical settings.
Despite its reputation as a difficult-to-treat pathogen, entero faecium also has a beneficial side. It is widely used as a probiotic in both human and veterinary health due to its ability to survive harsh gastrointestinal conditions, such as stomach acid and bile salts. Its resilience allows it to reach the intestines intact, where it can promote gut health by competing with harmful bacteria like Escherichia coli. In animals, particularly in livestock and poultry, Enterococcus Faecium Veterinary Probiotics is added to feed as a natural alternative to antibiotics, helping to enhance nutrient absorption, reduce gastrointestinal disorders, and improve growth performance.
E. faecium's dual role-as both a probiotic and a potential pathogen-makes it a significant subject of study in microbiology, medicine, and food science. On one hand, it supports digestive and immune health, while on the other, it poses challenges in clinical settings due to rising antibiotic resistance. Certain strains of E. faecium have become resistant to vancomycin (VRE: vancomycin-resistant enterococci), making them particularly concerning in hospitals.
In conclusion, Enterococcus faecium is a complex microorganism with a dual identity. It serves as a beneficial probiotic in food and feed applications, promoting gut balance and disease resistance. Yet, under certain circumstances, it can also act as a harmful pathogen. Understanding the behavior and characteristics of E. faecium is essential for developing effective treatments, maintaining food safety, and optimizing the use of probiotics in health and agriculture.